Frontiers in Physiology (Feb 2022)

Cell-to-Cell Communications in Alcohol-Associated Liver Disease

  • Natalia A. Osna,
  • Natalia A. Osna,
  • Akiko Eguchi,
  • Ariel E. Feldstein,
  • Hidekazu Tsukamoto,
  • Hidekazu Tsukamoto,
  • Raghubendra S. Dagur,
  • Raghubendra S. Dagur,
  • Murali Ganesan,
  • Murali Ganesan,
  • Moses New-Aaron,
  • Moses New-Aaron,
  • Madan Kumar Arumugam,
  • Madan Kumar Arumugam,
  • Srinivas Chava,
  • Srinivas Chava,
  • Marcelle Ribeiro,
  • Gyongyi Szabo,
  • Sebastian Mueller,
  • Shijin Wang,
  • Cheng Chen,
  • Steven A. Weinman,
  • Kusum K. Kharbanda,
  • Kusum K. Kharbanda,
  • Kusum K. Kharbanda

DOI
https://doi.org/10.3389/fphys.2022.831004
Journal volume & issue
Vol. 13

Abstract

Read online

This review covers some important new aspects of the alcohol-induced communications between liver parenchymal and non-parenchymal cells leading to liver injury development. The information exchange between various cell types may promote end-stage liver disease progression and involves multiple mechanisms, such as direct cell-to-cell interactions, extracellular vesicles (EVs) or chemokines, cytokines, and growth factors contained in extracellular fluids/cell culture supernatants. Here, we highlighted the role of EVs derived from alcohol-exposed hepatocytes (HCs) in activation of non-parenchymal cells, liver macrophages (LM), and hepatic stellate cells (HSC). The review also concentrates on EV-mediated crosstalk between liver parenchymal and non-parenchymal cells in the settings of HIV- and alcohol co-exposure. In addition, we overviewed the literature on the crosstalk between cell death pathways and inflammasome activation in alcohol-activated HCs and macrophages. Furthermore, we covered highly clinically relevant studies on the role of non-inflammatory factors, sinusoidal pressure (SP), and hepatic arterialization in alcohol-induced hepatic fibrogenesis. We strongly believe that the review will disclose major mechanisms of cell-to-cell communications pertained to alcohol-induced liver injury progression and will identify therapeutically important targets, which can be used for alcohol-associated liver disease (ALD) prevention.

Keywords